Loading organizations...
§ Private Profile · 5 Shenton Way, Singapore
SwipeRx is a technology company.
SwipeRx operates a medical technology platform that streamlines the pharmaceutical supply chain by connecting manufacturers, pharmacies, and patients. The company provides a comprehensive ecosystem enabling B2B commerce, professional community engagement, and access to essential industry information. Its offerings include tools for continuing professional development and critical news, fostering a more integrated and efficient network within the healthcare sector.
The company was founded in 2012 by Farouk Meralli, establishing its roots in Singapore. Meralli’s vision for SwipeRx emerged from a recognized need to modernize and interconnect the fragmented pharmaceutical landscape across Southeast Asia. This insight led to the creation of a unified digital solution to empower pharmacy professionals and improve access to medicines.
Pharmacy professionals across Southeast Asia are the primary users of SwipeRx, benefiting from its community features and commerce capabilities. The company’s long-term vision centers on enhancing the regional pharmaceutical ecosystem, driving professional development, and ultimately improving healthcare outcomes by ensuring better access to pharmaceutical products and knowledge.
SwipeRx has raised $33.0M across 2 funding rounds.
SwipeRx has raised $33.0M in total across 2 funding rounds.
SwipeRx has raised $33.0M across 2 funding rounds. Most recently, it raised $27.0M Series B in May 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 1, 2022 | $27M Series B | MDI Ventures | Flybridge Capital Partners, Bill & Melinda Gates Foundation, Johnson & Johnson Innovation, Susquehanna International Group | Announced |
| Feb 1, 2017 | $6M Series A | Beau Seil | Nokia Growth Partners, Winklevoss Capital, 500 Startups, Endeavor, Nishant Lalwani, IMJ Investment Partners, Kickstart Ventures, Nicko Widjaja | Announced |
SwipeRx has raised $33.0M in total across 2 funding rounds.
SwipeRx's investors include MDI Ventures, Flybridge Capital Partners, Bill & Melinda Gates Foundation, Johnson & Johnson Innovation, Susquehanna International Group, Beau Seil, Nokia Growth Partners, Winklevoss Capital, 500 Startups, Endeavor, Nishant Lalwani, IMJ Investment Partners.
SwipeRx is a technology company that builds a digital platform serving pharmacy professionals and retail pharmacies across Southeast Asia. Its core product is an all-in-one mobile app that connects pharmacists, provides accredited continuing professional development (CPD) education, industry news, a drug directory, and a B2B commerce tool for purchasing medicines. SwipeRx addresses the fragmentation of pharmacies in emerging markets by digitizing pharmacy practice, streamlining operations, and enabling access to affordable medicines, thereby improving patient care at scale. It has grown to become the largest digital pharmacy network in the region, connecting about one-third of pharmacists across countries including Indonesia, Thailand, the Philippines, Vietnam, Malaysia, and Cambodia, with over 300,000 pharmacy professionals from 50,000 pharmacies engaged[1][2][3][5].
Founded in 2012 and headquartered in Singapore, SwipeRx was created by a team led by founder Meralli, who identified logistical weaknesses and fragmentation in Southeast Asia’s pharmacy sector. The idea emerged from the need to empower pharmacies as central healthcare providers by connecting them digitally and providing education and supply chain access. Early traction included building the largest crowdsourced knowledge base for pharmacy practice and launching a Group Purchasing Organization that enabled independent pharmacies to access medicines at pre-negotiated prices. Strategic partnerships and investments, including support from J&J Impact Ventures and the Gates Foundation, have helped SwipeRx scale its platform and improve logistics and service delivery[2][3][5][4].
SwipeRx rides the global trend of digital health transformation, particularly in emerging markets where healthcare infrastructure is fragmented. The timing is critical as Southeast Asia experiences rapid mobile adoption and increasing demand for affordable, accessible healthcare. Market forces such as the need for better supply chain transparency, professional development for healthcare workers, and data-driven health policy create a favorable environment. SwipeRx influences the ecosystem by positioning pharmacies as central healthcare nodes, improving medicine access, and enabling real-time health data collection, which benefits governments, NGOs, and pharmaceutical companies alike[1][2][4].
Looking ahead, SwipeRx is poised to deepen its impact by expanding its digital layer across the entire healthcare supply chain in Southeast Asia. Trends shaping its journey include increasing digitization of healthcare, growing emphasis on data analytics for public health, and the rising role of pharmacies in primary care delivery. Its influence may evolve from a pharmacy-focused platform to a broader healthcare ecosystem enabler, integrating more stakeholders and services. Continued partnerships and innovation in logistics and financing will likely drive further growth and improved health outcomes in the region[2][5].
In summary, SwipeRx leverages technology to unify and empower fragmented pharmacy networks in Southeast Asia, improving access to medicines, education, and healthcare data, thereby transforming pharmacy-driven healthcare delivery at scale.